{"id":"https://openalex.org/W4361884479","doi":"https://doi.org/10.1158/1078-0432.22458789","title":"Supplementary Figure S5 from Personalized Preclinical Trials in BRAF Inhibitor\u2013Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies","display_name":"Supplementary Figure S5 from Personalized Preclinical Trials in BRAF Inhibitor\u2013Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361884479","doi":"https://doi.org/10.1158/1078-0432.22458789"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22458789","doi":"https://doi.org/10.1158/1078-0432.22458789","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22458789","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22458789","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037620517","display_name":"Clemens Krepler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clemens Krepler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067382998","display_name":"Min Xiao","orcid":"https://orcid.org/0000-0001-9421-6344","observed_orcids":["https://orcid.org/0000-0001-9421-6344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Xiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058997105","display_name":"Katrin Sproesser","orcid":"https://orcid.org/0009-0000-5043-6281","observed_orcids":["https://orcid.org/0009-0000-5043-6281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katrin Sproesser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051118651","display_name":"Patricia A. Brafford","orcid":"https://orcid.org/0000-0002-4836-7421","observed_orcids":["https://orcid.org/0000-0002-4836-7421"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia A. Brafford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022769141","display_name":"Batool Shannan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Batool Shannan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065799733","display_name":"Marilda Beqiri","orcid":"https://orcid.org/0000-0002-9738-0243","observed_orcids":["https://orcid.org/0000-0002-9738-0243"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marilda Beqiri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100432490","display_name":"Qin Liu","orcid":"https://orcid.org/0000-0001-9964-580X","observed_orcids":["https://orcid.org/0000-0001-9964-580X","https://orcid.org/0009-0000-3931-0813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qin Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115592426","display_name":"Wei Xu","orcid":"https://orcid.org/0009-0006-3042-608X","observed_orcids":["https://orcid.org/0009-0006-3042-608X","https://orcid.org/0000-0001-9341-8382","https://orcid.org/0009-0000-3819-4152","https://orcid.org/0000-0002-3265-7475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044963819","display_name":"Bradley Garman","orcid":"https://orcid.org/0000-0001-9641-4125","observed_orcids":["https://orcid.org/0000-0001-9641-4125"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradley Garman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072490052","display_name":"Katherine L. Nathanson","orcid":"https://orcid.org/0000-0002-6740-0901","observed_orcids":["https://orcid.org/0000-0002-6740-0901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine L. Nathanson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110634","display_name":"Xiaowei Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaowei Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035929126","display_name":"Giorgos Constantine Karakousis","orcid":"https://orcid.org/0000-0002-9321-2795","observed_orcids":["https://orcid.org/0000-0002-9321-2795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giorgos C. Karakousis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005221518","display_name":"Gordon Brent Mills","orcid":"https://orcid.org/0000-0002-0144-9614","observed_orcids":["https://orcid.org/0000-0002-0144-9614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gordon B. Mills","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020581776","display_name":"Yiling Lu","orcid":"https://orcid.org/0000-0002-3662-2106","observed_orcids":["https://orcid.org/0000-0002-3662-2106"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiling Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011684568","display_name":"Tamer A. Ahmed","orcid":"https://orcid.org/0000-0002-6922-6193","observed_orcids":["https://orcid.org/0000-0002-6922-6193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamer A. Ahmed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078118619","display_name":"Poulikos I. Poulikakos","orcid":"https://orcid.org/0000-0001-6071-9963","observed_orcids":["https://orcid.org/0000-0001-6071-9963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Poulikos I. Poulikakos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025118565","display_name":"Giordano Caponigro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giordano Caponigro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065761868","display_name":"Markus Boehm","orcid":"https://orcid.org/0000-0002-7025-3287","observed_orcids":["https://orcid.org/0000-0002-7025-3287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markus Boehm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Malte Peters","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malte Peters","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012671311","display_name":"Lynn Mara Schuchter","orcid":"https://orcid.org/0000-0002-0523-4346","observed_orcids":["https://orcid.org/0000-0002-0523-4346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lynn M. Schuchter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085589424","display_name":"Ashani T. Weeraratna","orcid":"https://orcid.org/0000-0003-0448-6952","observed_orcids":["https://orcid.org/0000-0003-0448-6952"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashani T. Weeraratna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028792712","display_name":"Meenhard Herlyn","orcid":"https://orcid.org/0000-0003-0839-0739","observed_orcids":["https://orcid.org/0000-0003-0839-0739"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meenhard Herlyn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.020800000056624413,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-inhibitor-resistance","display_name":"BRAF inhibitor resistance","score":0.9470000267028809},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9879999756813049},{"id":"https://openalex.org/keywords/preclinical-trials","display_name":"preclinical trials","score":0.4790000021457672},{"id":"https://openalex.org/keywords/relative-protein-abundance","display_name":"relative protein abundance","score":0.3959999978542328},{"id":"https://openalex.org/keywords/cancer-proteome","display_name":"tumor proteome","score":0.421999990940094},{"id":"https://openalex.org/keywords/principal-component-analysis","display_name":"principal component analysis","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C27438332","wikidata":"https://www.wikidata.org/wiki/Q2873","display_name":"Principal component analysis","level":2,"score":0.6256145238876343},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.521510899066925},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4118198752403259},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37732309103012085},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3519779443740845},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.12742751836776733},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.10096383094787598}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22458789","doi":"https://doi.org/10.1158/1078-0432.22458789","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22458789","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22458789","doi":"https://doi.org/10.1158/1078-0432.22458789","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22458789","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2207662183","https://openalex.org/W4361951697","https://openalex.org/W2565605759","https://openalex.org/W6939469711","https://openalex.org/W4361937782","https://openalex.org/W6920966076","https://openalex.org/W3140625850","https://openalex.org/W2404320321","https://openalex.org/W4361850562","https://openalex.org/W7098778048"],"abstract_inverted_index":{"A.":[0],"heat":[1,36],"map":[2,37],"of":[3,16,31,38,56],"complete":[4],"RPPA":[5],"data":[6,34],"median":[7,32],"centered,":[8],"all":[9],"tumor":[10,43],"grafts":[11,44],"untreated.":[12],"Data":[13],"are":[14],"mean":[15],"3":[17],"biological":[18],"replicates,":[19],"red":[20],"is":[21,24],"up,":[22],"green":[23],"down.":[25],"B.":[26],"Principal":[27,52],"component":[28,53],"analysis":[29,54],"(PCA)":[30,55],"centered":[33],"C.":[35],"fold":[39,57],"change":[40,58],"between":[41],"untreated":[42],"and":[45],"on":[46],"chronic":[47],"BRAF":[48],"inhibitor":[49],"therapy.":[50],"D.":[51],"data.":[59]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-04-05T00:00:00"}